TSCAN THERAPEUTICS INC (TCRX) Stock Cash Flow
NASDAQ:TCRX - Nasdaq - US89854M1018 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -131.48M | -127.50M | -89.22M | -66.22M | -48.63M | |||
| Depreciation Amortization | 3.53M | 4.11M | 5.36M | 5.14M | 3.33M | |||
| Change In Working Capital | 779.00K | 5.05M | 17.61M | -10.23M | -5.90M | |||
| Interest Paid | 2.69M | 2.88M | 3.00M | N/A | N/A | |||
| Other non cash items | 8.03M | 7.51M | 4.89M | 4.81M | 2.52M | |||
| OPERATING CASH FLOW | -119.14M | -110.82M | -61.36M | -66.50M | -48.68M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.65M | -3.83M | -3.15M | -4.23M | -9.94M | |||
| Other Investing Activity | -70.59M | -48.79M | -57.61M | N/A | N/A | |||
| INVESTING CASH FLOW | -75.25M | -52.61M | -60.76M | -4.23M | -9.94M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 15.31M | 0.00 | 29.35M | N/A | |||
| Stock Issued/Repurchased | N/A | 193.45M | 135.44M | 130.00K | 189.67M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -130.00K | N/A | |||
| FINANCING CASH FLOW | 207.98M | 208.76M | 135.44M | 29.36M | 189.67M | |||
| CHANGE IN CASH | 13.60M | 45.33M | 13.33M | -41.37M | 131.05M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -119.14M | -110.82M | -61.36M | -66.50M | -48.68M | |||
| Capital Expenditure | -4.65M | -3.83M | -3.15M | -4.23M | -9.94M | |||
| FREE CASH FLOW | -123.79M | -114.65M | -64.50M | -70.73M | -58.62M | |||
All data in USD